Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis
Miriam J. Smith(Manchester Academic Health Science Centre), D. Gareth Evans(Manchester Academic Health Science Centre), Naomi L. Bowers, Cecilie F. Rustad(University of Oslo), C. Geoff Woods(University of Cambridge), Andrew J. Wallace(St Mary's Hospital), Rosalie E. Ferner(Guy's and St Thomas' NHS Foundation Trust)
Cited by 119
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766